• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对幽门螺杆菌空泡毒素A(VacA)和细胞毒素相关蛋白A(CagA)的联合血清IgG反应可预测胃癌。

Combined serum IgG response to Helicobacter pylori VacA and CagA predicts gastric cancer.

作者信息

Janulaityte-Günther Daiva, Kupcinskas Limas, Pavilonis Alvydas, Valuckas Konstantinas, Wadström Torkel, Andersen Leif Percival

机构信息

Department of Microbiology, University of Medicine, Kaunas, Lithuania.

出版信息

FEMS Immunol Med Microbiol. 2007 Jul;50(2):220-5. doi: 10.1111/j.1574-695X.2007.00268.x.

DOI:10.1111/j.1574-695X.2007.00268.x
PMID:17567283
Abstract

Helicobacter pylori is a major factor for the development of gastric cancer. The aim of this study was to define serum antibody patterns associated with H. pylori infection in patients with gastric cancer using a Western blot technique. Serum samples collected from 115 patients with gastric cancer and 110 age- and gender-matched patients without gastrointestinal diseases were tested for IgG antibodies to H. pylori antigens (outer membrane proteins and whole cell preparations). No significant differences were found between patients with and without gastric cancer using outer membrane proteins (82% and 73%, P>0.05) or whole cell antigens (84% and 76%, P>0.05), respectively. The significant differences between patients with and without gastric cancer were associated with bands of 94 kDa (54% and 20%, P<0.001) and 30 kDa (65% and 44%, P<0.01). A combination of antibodies to 85 kDa (VacA) and 120 kDa (CagA) was significantly (P<0.01) more frequent in gastric cancer patients than in patients without gastric cancer. The detection of antibodies to 94- and 30-kDa bands, in association with the determination of serum antibodies to CagA+/VacA+, may have a prospective value in assessment of the risk of developing of gastric cancer.

摘要

幽门螺杆菌是胃癌发生的主要因素。本研究的目的是使用蛋白质印迹技术确定胃癌患者中与幽门螺杆菌感染相关的血清抗体模式。对115例胃癌患者以及110例年龄和性别匹配的无胃肠道疾病患者采集的血清样本检测幽门螺杆菌抗原(外膜蛋白和全菌制剂)的IgG抗体。分别使用外膜蛋白(82%和73%,P>0.05)或全菌抗原(84%和76%,P>0.05)时,胃癌患者与非胃癌患者之间未发现显著差异。胃癌患者与非胃癌患者之间的显著差异与94 kDa条带(54%和20%,P<0.001)和30 kDa条带(65%和44%,P<0.01)有关。与无胃癌患者相比,胃癌患者中85 kDa(VacA)和120 kDa(CagA)抗体的组合明显更常见(P<0.01)。检测94 kDa和30 kDa条带的抗体,结合检测CagA+/VacA+血清抗体,可能对评估胃癌发生风险具有前瞻性价值。

相似文献

1
Combined serum IgG response to Helicobacter pylori VacA and CagA predicts gastric cancer.对幽门螺杆菌空泡毒素A(VacA)和细胞毒素相关蛋白A(CagA)的联合血清IgG反应可预测胃癌。
FEMS Immunol Med Microbiol. 2007 Jul;50(2):220-5. doi: 10.1111/j.1574-695X.2007.00268.x.
2
Serum antibody positivity for distinct Helicobacter pylori antigens in benign and malignant gastroduodenal disease.良性和恶性胃十二指肠疾病中针对不同幽门螺杆菌抗原的血清抗体阳性情况。
Int J Med Microbiol. 2006 Aug;296(4-5):223-8. doi: 10.1016/j.ijmm.2006.02.009.
3
Serological response to specific Helicobacter pylori antigens: antibody against CagA antigen is not predictive of gastric cancer in a developing country.对特定幽门螺杆菌抗原的血清学反应:在一个发展中国家,抗CagA抗原抗体不能预测胃癌。
Am J Gastroenterol. 1996 Sep;91(9):1785-8.
4
Helicobacter pylori antibodies and gastric cancer: a gender-related difference.幽门螺杆菌抗体与胃癌:性别相关差异
FEMS Immunol Med Microbiol. 2005 May 1;44(2):191-5. doi: 10.1016/j.femsim.2004.11.011.
5
Seroreactivity to specific antigens of Helicobacter pylori infection is associated with an increased risk of the dyspeptic gastrointestinal diseases.对幽门螺杆菌感染特定抗原的血清反应性与消化不良性胃肠疾病风险增加相关。
Int J Infect Dis. 2009 Sep;13(5):647-54. doi: 10.1016/j.ijid.2008.12.013. Epub 2009 Feb 23.
6
[Evaluation of Western Blot method for the detection of antibodies to Helicobacter pylori antigens in patients with gastric carcinoma and cases with epigastric complaints].[对胃癌患者及有上腹部不适症状者检测幽门螺杆菌抗原抗体的蛋白质印迹法评估]
Mikrobiyol Bul. 2010 Jan;44(1):21-8.
7
Impact of Helicobacter pylori infection on the humoral immune response to MUC1 peptide in patients with chronic gastric diseases and gastric cancer.幽门螺杆菌感染对慢性胃病和胃癌患者针对MUC1肽的体液免疫反应的影响。
Immunol Invest. 2007;36(4):371-86. doi: 10.1080/08820130601109727.
8
Antibodies to CagA protein are associated with gastric atrophy in Helicobacter pylori infection.抗CagA蛋白抗体与幽门螺杆菌感染中的胃萎缩相关。
Eur J Gastroenterol Hepatol. 1996 Jul;8(7):645-9.
9
Role of gastrin in gastric cancerogenesis in Helicobacter pylori infected humans.胃泌素在幽门螺杆菌感染人群胃癌发生中的作用。
J Physiol Pharmacol. 1999 Dec;50(5):857-73.
10
Response of IgG1 and IgG2 subclasses to Helicobacter pylori in subjects with chronic inflammation of the gastric mucosa, atrophy and gastric cancer in a country with high Helicobacter pylori infection prevalence.在幽门螺杆菌感染率高的国家,胃黏膜慢性炎症、萎缩及胃癌患者中IgG1和IgG2亚类对幽门螺杆菌的反应
APMIS. 2006 May;114(5):372-80. doi: 10.1111/j.1600-0463.2006.apm_392.x.

引用本文的文献

1
Epitope peptides of Helicobacter pylori CagA antibodies from sera by whole-peptide mapping.通过全肽图谱分析从血清中鉴定出幽门螺杆菌 CagA 抗体的表位肽。
J Gastroenterol. 2019 Dec;54(12):1039-1051. doi: 10.1007/s00535-019-01584-8. Epub 2019 May 2.
2
Diagnosis of : Changes towards the Future.诊断:迈向未来的变革
Diseases. 2015 Jun 29;3(3):122-135. doi: 10.3390/diseases3030122.
3
A review of Helicobacter pylori diagnosis, treatment, and methods to detect eradication.幽门螺杆菌的诊断、治疗及根除检测方法综述
World J Gastroenterol. 2014 Feb 14;20(6):1438-49. doi: 10.3748/wjg.v20.i6.1438.
4
Helicobacter pylori protein-specific antibodies and risk of colorectal cancer.幽门螺杆菌蛋白特异性抗体与结直肠癌风险。
Cancer Epidemiol Biomarkers Prev. 2013 Nov;22(11):1964-74. doi: 10.1158/1055-9965.EPI-13-0702. Epub 2013 Sep 17.
5
Biomarkers of Helicobacter pylori-associated gastric cancer.幽门螺杆菌相关性胃癌的生物标志物。
Gut Microbes. 2013 Nov-Dec;4(6):532-40. doi: 10.4161/gmic.25720. Epub 2013 Jul 12.